IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14

Reporting Person: Hunt Nimrata (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-14	Common Stock	M	199	—	Acquired	7784	Direct
2021-02-14	Common Stock	M	88	—	Acquired	7872	Direct
2021-02-14	Common Stock	M	126	—	Acquired	7998	Direct
2021-02-14	Common Stock	M	127	—	Acquired	8125	Direct
2021-02-14	Common Stock	M	174	—	Acquired	8299	Direct
2021-02-14	Common Stock	F	216	$544.08	Disposed	8083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-14	Non-Qualified Stock Option (right-to-buy)	$544.08	A	6003	Acquired	2031-02-13	Common Stock (6003)	Direct
2021-02-14	Incentive Stock Option (right-to-buy)	$544.08	A	183	Acquired	2031-02-13	Common Stock (183)	Direct
2021-02-14	Restricted Stock Unit	$	A	643	Acquired		Common Stock (643)	Direct
2021-02-14	Restricted Stock Unit	$	M	199	Disposed		Common Stock (199)	Direct
2021-02-14	Restricted Stock Unit	$	M	88	Disposed		Common Stock (88)	Direct
2021-02-14	Restricted Stock Unit	$	M	126	Disposed		Common Stock (126)	Direct
2021-02-14	Restricted Stock Unit	$	M	127	Disposed		Common Stock (127)	Direct
2021-02-14	Restricted Stock Unit	$	M	174	Disposed		Common Stock (174)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	160	Indirect

Footnotes

F1: Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.

F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.

F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F11: Not applicable.